Are you a diversity scholar interested in data science and Down syndrome? Join us in July for a workshop! app.smartsheet.com/b/publish…
Locked out of the wetlab on account of the earliest COVID lockdown (in 2020) -- and one student turns the situation into a nice piece of work. Read our latest paper @ BMC Genomics rdcu.be/cIt2W
Robin Dowell retweeted
It's out (pubmed.ncbi.nlm.nih.gov/3437… )! Ever noticed that most host-pathogen studies are done with macrophages from immune compromised mice that lack functional NRAMP1? Well, if you are interested in metals at the host-pathogen interface, read on...1/
Robin Dowell retweeted
How is p53 regulated? Paper with @rddowell in @PLOSBiology shows D40p53 isoform tempers WTp53 activity to allow input from other TFs. Surprisingly, D40p53 blocks WTp53-dependent eRNA transcription and prevents mRNA biogenesis despite pre-mRNA induction bit.ly/3kk7nBN
Robin Dowell retweeted
BioFrontiers Institute HPC System/Software Administrator jobs.colorado.edu/jobs/JobDe…
We are still adding to our staff. Please check out our HPC position.
Another collaborator looking for good people!
Interested in embryonic development, stem cells, chromatin, and RNA? The Brumbaugh lab is looking to hire a talented PRA/lab manager. Check us out and please RT!
jobs.colorado.edu/jobs/JobDe…
We collaborate with the Taatjes lab and look forward to working with applicants!
The Taatjes lab @TaatjesL @CUBIOCHEM1 is hiring talented postdocs for high-impact projects in transcription regulation. See @NatureCareers and @PostdocJobs or go.nature.com/37eEuA5 for details. #postdocposition #postdoc
Our most recent collab paper...
In this study, Rimel et al. demonstrate a widespread requirement for CDK7 activity in splicing, and unexpected aspects of CDK7 kinase regulation that involve its association with TFIIH. @CUBIOCHEM1 @CUBoulder
genesdev.cshlp.org/content/3…
Robin Dowell retweeted
We are hiring
The HPC System/Software Administrator will be a key member of the BioFrontiers IT team, passionate about providing technical assistance, software management
More information
BioFrontiers Institute HPC System/Software Administrator jobs.colorado.edu/jobs/JobDe…
Robin Dowell retweeted
Incredibly excited to be selected as one of the @PackardFdn 2020 #PackardFellows! Such an honor to join this inspiring community of scientists as I further my research in genome evolution and #transposons.
bit.ly/fellows20
Replying to @PackardFdn
Meet the newest #PackardFellows: At @CUBoulder, @edchuong researches virus-like parasites called transposons to better understand differences in #immune responses across individuals and species. Learn more: bit.ly/fellows20. #biology @BioFrontiers
Always a great day when a former undergrad reaches their next milestone. Congrats Phil!
Congrats to my old friend Paul!
Every year, EMBO recognises outstanding researchers in the #lifesciences.
Congratulations to EMBL's Alexander Aulehla & Paul Flicek for being elected as new @EMBO members by their peers! #EMBOMember #ScienceAward
🎉 embl.org/news/lab-matters/em…
My second favorite little start up is starting to gain traction!
This Post is from an account that no longer exists. Learn more
Fun working with Palmer lab on zinc remodeling
Remodeling of zinc during mammary cell differentiation is caused primarily by signaling through glucocorticoid receptor. Great work by PhD students You Han and Lynn Sanford. pubs.rsc.org/en/content/arti… .
Our latest preprint is now in the bioRxiv! doi.org/10.1101/2020.01.25.9…
My favorite little biotech is growing ...
Arpeggio is thrilled to share news of our $3.2 million seed financing round, as well as updates on our progress over the last year. We're excited to have this support to drive forward the ongoing development of a nascent RNA drug screen.
businesswire.com/news/home/2…
Robin Dowell retweeted
We are so proud to announce that Joey Azofeifa, our CEO and Founder, has been named to the #ForbesUnder30 list in Healthcare! We're feeling grateful for all the opportunities Arpeggio has had this year.
Robin Dowell retweeted
Our new paper is out today. We used CRISPR to uncover some really striking findings with several drugs and drug targets in clinical trials. Also, we accidentally found the first-ever inhibitor of the cyclin-dependent kinase CDK11. stm.sciencemag.org/content/1…





















